N. Iscoe
Impact in
- Oncology top 10%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Global Cancer Incidence and Screening
- Lung Cancer Research Studies
-
- Prostate Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 16
- Lung Cancer Research Studies 4
- Cancer Treatment and Pharmacology 3
- Cutaneous Melanoma Detection and Management 3
- Cancer survivorship and care 3
-
- Prostate Cancer Diagnosis and Treatment 5
- Prostate Cancer Treatment and Research 4
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Vivek Goel (3 shared papers)Ian Quirt (5 shared papers)Eric J. Holowaty (2 shared papers)Gordon Fehringer (2 shared papers)C. David Naylor (2 shared papers)Kejin Wu (1 shared paper)Isra Levy (2 shared papers)A. Bodurtha (3 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Annals of Oncology (2 papers)Value in Health (2 papers)The Journal of Urology (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
N. Iscoe
25 papers receiving 565 citations
Peers
Comparison fields: 5 of 77
- Oncology 358
- Pulmonary and Respiratory Medicine 170
- Medical Terminology 1
- Cancer Research 44
- Immunology 61
Countries citing papers authored by N. Iscoe
This map shows the geographic impact of N. Iscoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Iscoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Iscoe more than expected).
Fields of papers citing papers by N. Iscoe
This network shows the impact of papers produced by N. Iscoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Iscoe. The network helps show where N. Iscoe may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Iscoe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 118 | |
| 2 | Variation in breast cancer surgery in Ontario. | 1994 | 72 |
| 3 | 2008 | 64 | |
| 4 | 2005 | 53 | |
| 5 | 1998 | 33 | |
| 6 | Results of a survey of Canadian men with prostate cancer. | 1997 | 32 |
| 7 | 1985 | 30 | |
| 8 | Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer. | 1999 | 28 |
| 9 | 1993 | 24 | |
| 10 | 1987 | 23 | |
| 11 | 2022 | 22 | |
| 12 | Temporal trends in breast cancer surgery in Ontario: can one randomized trial make a difference? | 1994 | 18 |
| 13 | Prostate cancer: 1. The descriptive epidemiology in Canada. | 1998 | 17 |
| 14 | Re-evaluating the cost of outpatient cancer chemotherapy. | 1987 | 15 |
| 15 | Predicting psychological distress in patients with cancer: conceptual basis and reliability evaluation of a self-report questionnaire. | 1995 | 11 |
| 16 | Prostate cancer patients' satisfaction with medical information. | 1997 | 8 |
| 17 | 1993 | 7 | |
| 18 | A 3-week gemcitabine-cisplatin regimen for metastatic urothelial cancer. | 2004 | 4 |
| 19 | Orchidectomy and hormonal therapy of prostate cancer. | 1995 | 3 |
| 20 | Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma. | 1985 | 3 |
About N. Iscoe
N. Iscoe is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Economics and Econometrics, having authored 26 papers that have together received 594 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (5 papers), Lung Cancer Research Studies (4 papers), Prostate Cancer Treatment and Research (4 papers), Cancer Treatment and Pharmacology (3 papers), Cutaneous Melanoma Detection and Management (3 papers), Melanoma and MAPK Pathways (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer survivorship and care (3 papers). The work is most often cited by research in Oncology (358 citations), Pulmonary and Respiratory Medicine (170 citations), Medical Terminology (1 citation), Cancer Research (44 citations) and Immunology (61 citations). N. Iscoe has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Vivek Goel, Ian Quirt, Eric J. Holowaty, Gordon Fehringer, C. David Naylor, Kejin Wu, Isra Levy, A. Bodurtha, George Deboer and David Osoba. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology, Value in Health and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.